Status:

COMPLETED

FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer

Lead Sponsor:

UMC Utrecht

Conditions:

Prostate Cancer

Radiotherapy

Eligibility:

MALE

18+ years

Phase:

PHASE3

Brief Summary

Rationale: Dose escalation in external-beam irradiation has proven to benefit outcome in local prostate cancer. Randomized trials were performed up to doses of 78 Gy in 2 Gy fractions. Nevertheless, t...

Detailed Description

Objective: * Primary study objective: To demonstrate the superiority of the ablative microboost dose schedule regarding 5-year biochemical no evidence of disease rate compared to the current standard...

Eligibility Criteria

Inclusion

  • Prostate cancer patients scheduled for external beam radiotherapy using IMRT and fiducial marker-based position verification
  • Intermediate and high risk prostate cancer, defined by Ash et al. 2000, namely:
  • One or more factors: T2, or Gleasonscore \>7, or iPSA \> 10 ng/mL
  • WHO score 0-2

Exclusion

  • Low risk prostate cancer, defined by Ash et al. 2000
  • World Heath Organisation (WHO) score \>2
  • International Prostate Symptom Score (IPSS) \>20
  • If for any patient related reason an MRI cannot be performed
  • If anticoagulation cannot be stopped temporarily regarding the implant of fiducial markers
  • Previous prostatectomy (except from Trans Urethral Prostatectomy (TURP))
  • TURP within 3 months from start treatment
  • Previous pelvic irradiation

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2016

Estimated Enrollment :

571 Patients enrolled

Trial Details

Trial ID

NCT01168479

Start Date

September 1 2009

End Date

January 1 2016

Last Update

June 2 2020

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University Hospitals Leuven

Leuven, Vlaans-Brabant, Belgium, 3000

2

Radboud UMC

Nijmegen, Gelderland, Netherlands, 6500HB

3

NKI-AvL

Amsterdam, North Holland, Netherlands, 1066CX

4

University Medical Center Utrecht

Utrecht, Netherlands, 3584CX